Cite
HARVARD Citation
Home, P. et al. (2023). Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics. Diabetes, obesity & metabolism. 25 (3), pp. 656-663. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Home, P. et al. (2023). Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics. Diabetes, obesity & metabolism. 25 (3), pp. 656-663. [Online].